Compare therapy apps vs in-person therapy in this guide exploring online therapy effectiveness, key pros and cons, and how digital mental health apps support emotional well-being.
Patients with depression who received the Moodivate app saw clinically meaningful reductions in their symptoms that were twice those achieved with standard-of-care therapy in a clinical trial ...
Use of an app-based digital therapeutic significantly reduces urinary incontinence episodes when added to usual care in women with stress, urge, or mixed urinary incontinence, according to results of ...
The allure of therapy apps is undeniable – instant access to mental health support from your smartphone. During lockdowns, these platforms saw unprecedented growth as people sought ways to cope with ...
Pear Therapeutics, a Boston and San Francisco-based developer of digital strategies to address a broad range of mental health conditions, has released results of a study showing promising engagement ...
Therapy apps existed well before the pandemic, when the field pivoted to a mostly virtual world. But they marketed heavily during quarantine and the time following, for obvious reasons, and don’t seem ...
In March 2025, researchers published the results of the first randomized controlled trial for an “expert-fine-tuned” generative artificial intelligence-powered chatbot for mental health treatment.[1] ...
Open any app store on your phone and you’ll find no shortage of promises: quit smoking, lose weight, beat anxiety, lull yourself to sleep, recover from addiction. From guided journaling and behavioral ...
Please provide your email address to receive an email when new articles are posted on . “Due to limited medical resources as well as geographic, time and financial constraints, mastering the ...
“We know that long wait times worsen symptoms, so that is the gap we were trying to address: to provide immediate access to affirming clinical therapy,” says Daniel Botcherby, the chief executive and ...
CT-155 (Boehringer Ingelheim and Click Therapeutics), an investigational prescription digital therapeutic, was both safe and effective in reducing negative symptoms of schizophrenia in a new phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results